Abstract
Gut microbiota modulation by a probiotic is a novel therapy for hypercholesterolemia mitigation. This study initially investigated the potential hypocholesterolemic effect of Bacillus sp. DU-106 in hypercholesterolemic rats and explored its potential relation with gut microbiota. Sprague–Dawley rats received a high-fat diet, or a high-fat diet supplemented with 7.5 × 109 and 1.5 × 1010 CFU/kg bw/day Bacillus sp. DU-106 (low-dose and high-dose groups). At the end of 9 weeks, Bacillus sp. DU-106 treatment significantly decreased the body weight, liver index, and total cholesterol. 16S rRNA sequencing showed that Bacillus sp. DU-106 intervention significantly increased bacterial richness and particularly increased the genus abundance of Turicibacter, Acinetobacter, Brevundimonas, and Bacillus and significantly decreased the abundance of Ralstonia. Metabolomic data further indicated that the supplementation of Bacillus sp. DU-106 remarkably changed the gut metabolic profiles of hypercholesterolemic rats and, in particular, elevated the metabolites of indole-3-acetate, methylsuccinic acid, creatine, glutamic acid, threonine, lysine, ascorbic acid, and pyridoxamine. Spearman’s correlation analysis showed the close relation between the different genera and metabolites. In conclusion, Bacillus sp. DU-106 supplement ameliorated high-fat diet-induced hypercholesterolemia and showed potential probiotic benefits for the intestine.
Key points
• A novel potential probiotic Bacillus sp. DU-106 ameliorated hypercholesterolemia in rats.
• Bacillus sp. DU-106 supplement regulated gut microbiome structure and richness.
• Bacillus sp. DU-106 supplement changed metabolic profiles in high-fat diet rats.
• Significant correlations were observed between differential genera and metabolites.
Similar content being viewed by others
References
Aderiye B, David O (2013) In vivo evaluation of hypolipidemic potentials of Bacillus species isolated from fermented locust bean (Parkia fillicoides Welw) seeds (Iru). Microbiol Res J Int 3:574–584. https://doi.org/10.9734/BMRJ/2013/5026
Alkanany FN, Gmais SA, Maki AA, Altaee AM (2017) Estimation of bacterial biodegradability of PAH in Khor Al-Zubair Channel, southern Iraq. Int J Mar Sci 7:42
Amar J, Serino M, Lange C, Chabo C, Iacovoni J, Mondot S, Lepage P, Klopp C, Mariette J, Bouchez O (2011) Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept. Diabetologia 54(12):3055–3061
Aminlari L, Shekarforoush SS, Hosseinzadeh S, Nazifi S, Sajedianfard J, Eskandari MH (2018) Effect of probiotics Bacillus coagulans and Lactobacillus plantarum on lipid profile and feces bacteria of rats fed cholesterol-enriched diet. Probiotics Antimicrob Proteins 11:1163–1171
Bassols J, Serino M, Carreras-Badosa G, Burcelin R, Blasco-Baque V, Lopez-Bermejo A, Fernandez-Real JM (2016) Gestational diabetes is associated with changes in placental microbiota and microbiome. Pediatr Res 80(6):777–784
Blachier F, Claire B, Cécile B, Daniel T (2009) Metabolism and functions of L-glutamate in the epithelial cells of the small and large intestines. Am J Clin Nutr 90(3):814S–821S. https://doi.org/10.3945/ajcn.2009.27462S
Caesar R, Tremaroli V, Kovatcheva-Datchary P, Cani P, Bäckhed F (2015) Crosstalk between gut microbiota and dietary lipids aggravates WAT inflammation through TLR signaling. Cell Metab 22(4):658–668
Chen D, Yang Z, Xia C, Huang Y, Yin B, Guo F, Zhao H, Zhao T, Qu H, Huang J (2014) The effect of Lactobacillus rhamnosus hsryfm 1301 on the intestinal microbiota of a hyperlipidemic rat model. BMC Complement Altern Med 14(1):386
Choo JM, Trim PJ, Leong LEX, Abell GCJ, Brune C, Jeffries N, Wesselingh S, Dear TN, Snel MF, Rogers GB (2017) Inbred mouse populations exhibit intergenerational changes in intestinal microbiota composition and function following introduction to a facility. Front Microbiol 8(26191):608
Collins KH, Paul HA, Hart DA, Reimer RA, Smith IC, Rios JL, Seerattan RA, Herzog W (2016) A high-fat high-sucrose diet rapidly alters muscle integrity, inflammation and gut microbiota in male rats. Sci Rep 6:37278
Costantini L, Molinari R, Farinon B, Merendino N (2017) Impact of omega-3 fatty acids on the gut microbiota. Int J Mol Sci 18(12):2645
Coursin DB (1961) Present status of vitamin B6 metabolism. Am J Clin Nutr 9(3):304–314
Cui Y, Blumenthal RS, Flaws JA, Whiteman MK, Langenberg P, Bachorik PS, Bush TL (2001) Non–high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 161(11):1413–1419
da Silva RP, Leonard K-A, Jacobs RL (2017) Dietary creatine supplementation lowers hepatic triacylglycerol by increasing lipoprotein secretion in rats fed high-fat diet. J Nutr Biochem 50:46–53
Dambekodi P, Gilliland S (1998) Incorporation of cholesterol into the cellular membrane of Bifidobacterium longum. J Dairy Sci 81(7):1818–1824
Dionysia K, Laura LF, Kelly S, Gannon MC, Nuttall FQ (2009) Lysine ingestion markedly attenuates the glucose response to ingested glucose without a change in insulin response. Am J Clin Nutr 90(2):314–320
Elshaghabee FMF, Namita R, Chetan S, Harsh P (2017) Bacillus as potential probiotics: status, concerns, and future perspectives. Front Microbiol 8:1490
Farnier M, Davignon J (1998) Current and future treatment of hyperlipidemia: the role of statins. Am J Cardiol 82(4B):3J–10J
Farwell WR, Sesso HD, Buring JE, Gaziano JM (2005) Non–high-density lipoprotein cholesterol versus low-density lipoprotein cholesterol as a risk factor for a first nonfatal myocardial infarction. Am J Cardiol 96(8):1129–1134
Fu J, Bonder MJ, Cenit MC, Tigchelaar EF, Maatman A, Dekens JA, Brandsma E, Marczynska J, Imhann F, Weersma RK (2015) The gut microbiome contributes to a substantial proportion of the variation in blood lipids. Circ Res 117(9):817–824
Grundy SM, Ahrens EH Jr, Salen G, Schreibman PH, Nestel PJ (1972) Mechanisms of action of clofibrate on cholesterol metabolism in patients with hyperlipidemia. J Lipid Res 13(4):531–551
Holme I, Aastveit A, Jungner I, Walldius G (2008) Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow-up periods in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med 264(1):30–38
Hou Y, Shao W, Xiao R, Xu K, Ma Z, Johnstone BH, Du Y (2009) Pu-erh tea aqueous extracts lower atherosclerotic risk factors in a rat hyperlipidemia model. Exp Gerontol 44(6–7):434–439
Islam J, Sato S, Watanabe K, Watanabe T, Hirahara K, Aoyama Y, Tomita S, Aso H, Komai M, Shirakawa H (2017) Dietary tryptophan alleviates dextran sodium sulfate-induced colitis through aryl hydrocarbon receptor in mice. J Nutr Biochem 42:43–50
Jacobson TA, Ito MK, Maki KC, Orringer CE, Bays HE, Jones PH, McKenney JM, Grundy SM, Gill EA, Wild RA (2015) National lipid association recommendations for patient-centered management of dyslipidemia: part 1—full report. J Clin Lipidol 9(2):129–169
Jiao N, Baker SS, Nugent CA, Tsompana M, Cai L, Wang Y, Buck MJ, Genco RJ, Baker RD, Zhu R (2018) Gut microbiome may contribute to insulin resistance and systemic inflammation in obese rodents: a meta-analysis. Physiol Genomics 50:224–254
Johnson AM, Costanzo A, Gareau MG, Armando AM, Quehenberger O, Jameson JM, Olefsky JM (2015) High fat diet causes depletion of intestinal eosinophils associated with intestinal permeability. PLoS One 10(4):e0122195
Kazak L, Chouchani ET, Lu GZ, Jedrychowski MP, Bare CJ, Mina AI, Kumari M, Zhang S, Vuckovic I, Laznik-Bogoslavski D (2017) Genetic depletion of adipocyte creatine metabolism inhibits diet-induced thermogenesis and drives obesity. Cell Metab 26(4):660–671.e3
Kazak L, Rahbani JF, Samborska B, Lu GZ, Jedrychowski MP, Lajoie M, Zhang S, Ramsay L, Dou FY, Tenen D, Chouchani ET, Dzeja P, Watson IR, Tsai L, Rosen ED, Spiegelman BM (2019) Ablation of adipocyte creatine transport impairs thermogenesis and causes diet-induced obesity. Nat Metab 1(3):360–370. https://doi.org/10.1038/s42255-019-0035-x
Koistinen VM, Kärkkäinen O, Borewicz K, Zarei I, Jokkala J, Micard V, Rosa-Sibakov N, Auriola S, Aura A-M, Smidt H, Hanhineva K (2019) Contribution of gut microbiota to metabolism of dietary glycine betaine in mice and in vitro colonic fermentation. Microbiome 7(1):103. https://doi.org/10.1186/s40168-019-0718-2
Korem T, Zeevi D, Zmora N, Weissbrod O, Bar N, Lotan-Pompan M, Avnit-Sagi T, Kosower N, Malka G, Rein M (2017) Bread affects clinical parameters and induces gut microbiome-associated personal glycemic responses. Cell Metab 25(6):1243–1253
Krishnan S, Ding Y, Saedi N, Choi M, Sridharan GV, Sherr DH, Yarmush ML, Alaniz RC, Jayaraman A, Lee K (2018) Gut microbiota-derived tryptophan metabolites modulate inflammatory response in hepatocytes and macrophages. Cell Rep 23(4):1099–1111
Kumar M, Nagpal R, Kumar R, Hemalatha R, Verma V, Kumar A, Chakraborty C, Singh B, Marotta F, Jain S (2012) Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases. Exp Diabetes Res 2012:902917
Li M, Shu X, Xu H, Zhang C, Yang L, Zhang L, Ji G (2016) Integrative analysis of metabolome and gut microbiota in diet-induced hyperlipidemic rats treated with berberine compounds. J Transl Med 14(1):237
Li P, Tian W, Jiang Z, Liang Z, Wu X, Du B (2018) Genomic characterization and probiotic potency of Bacillus sp. DU-106, a highly effective producer of L-lactic acid isolated from fermented yogurt. Front Microbiol. https://doi.org/10.3389/fmicb.2018.02216
Li X, Cao Z, Yang Y, Chen L, Liu J, Lin Q, Qiao Y, Zhao Z, An Q, Zhang C (2019) Correlation between jejunal microbial diversity and muscle fatty acids deposition in broilers reared at different ambient temperatures. Sci Rep 9(1):1–12
Lin IC, Yamashita S, Murata M, Kumazoe M, Tachibana H (2016) Equol suppresses inflammatory response and bone erosion due to rheumatoid arthritis in mice. J Nutr Biochem 32:101–106
Liong M, Shah N (2005) Bile salt deconjugation ability, bile salt hydrolase activity and cholesterol co-precipitation ability of Lactobacilli strains. Int Dairy J 15(4):391–398
Liu J, Sempos CT, Donahue RP, Dorn J, Trevisan M, Grundy SM (2006) Non–high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease. Am J Cardiol 98(10):1363–1368
Liu Z, Jeppesen PB, Gregersen S, Chen X, Hermansen K (2007) Dose- and glucose-dependent effects of amino acids on insulin secretion from isolated mouse islets and clonal INS-1E beta-cells. Rev Diabet Stud 5(4):232
Liu W, Crott JW, Lyu L, Pfalzer AC, Li J, Choi S-W, Yang Y, Mason JB, Liu Z (2016) Diet-and genetically-induced obesity produces alterations in the microbiome, inflammation and Wnt pathway in the intestine of Apc+/1638N mice: comparisons and contrasts. J Cancer 7(13):1780–1790
Liu H, Chen X, Hu X, Niu H, Tian R, Wang H, Pang H, Jiang L, Qiu B, Chen X, Zhang Y, Ma Y, Tang S, Li H, Feng S, Zhang S, Zhang C (2019) Alterations in the gut microbiome and metabolism with coronary artery disease severity. Microbiome 7(1):68. https://doi.org/10.1186/s40168-019-0683-9
Liua M, Mab L, Chena Q, Zhanga P, Chena C (2018) Fucoidan alleviates dyslipidemia and modulates gut microbiota in high-fat diet-induced mice. J Funct Foods 48:220–227
Mantziari A, Aakko J, Kumar H (2016) The impact of storage conditions on the stability of Lactobacillus rhamnosus GG and Bifidobacterium animalis subsp. lactis Bb12 in human milk. Breastfeed Med 12(9):566
Marchesi JR, Adams DH, Fava F, Hermes GD, Hirschfield GM, Hold G, Quraishi MN, Kinross J, Smidt H, Tuohy KM (2016) The gut microbiota and host health: a new clinical frontier. Gut 65(2):330–339
Martin M (2011) Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J 17(1):14806
Martín-Calvo N, Martínez-González MÁ (2017) Vitamin C intake is inversely associated with cardiovascular mortality in a cohort of Spanish graduates: the SUN project. Nutrients 9(9):954
Martínez I, Wallace G, Zhang C, Legge R, Benson AK, Carr TP, Moriyama EN, Walter J (2009) Diet-induced metabolic improvements in a hamster model of hypercholesterolemia are strongly linked to alterations of the gut microbiota. Appl Environ Microbiol 75(12):4175–4184
Neis EPJG, Dejong CHC, Rensen SS (2015) The role of microbial amino acid metabolism in host metabolism. Nutrients 7(4):2930–2946
Nie Q, Chen H, Hu J, Gao H, Fan L, Long Z, Nie S (2018) Arabinoxylan attenuates type 2 diabetes by improvement of carbohydrate, lipid, and amino acid metabolism. Mol Nutr Food Res 62:1800222. https://doi.org/10.1002/mnfr.201800222
Ottosson F, Brunkwall L, Ericson U, Nilsson PM, Almgren P, Fernandez C, Melander O, Orho-Melander M (2018) Connection between BMI related plasma metabolite profile and gut microbiota. J Clin Endocrinol Metab 103(4):1491–1501
Ouwehand AC (2017) A review of dose-responses of probiotics in human studies. Benefic Microbes 8(2):143–151
Panel ED, Grundy SM (2013) An international atherosclerosis society position paper: global recommendations for the management of dyslipidemia. J Clin Lipidol 7(6):561–565
Qiu L, Tao X, Xiong H, Yu J, Wei H (2018) Lactobacillus plantarum ZDY04 exhibits a strain-specific property of lowering TMAO via the modulation of gut microbiota in mice. Food Funct 9(8):4299–4309
Raquel FS, Elizabeth HN, Beatriz TI, Aline L, Leadir LMF, Angelica OB, Marina VC (2019) Survival and stability of Lactobacillus fermentum and Wickerhamomyces anomalus strains upon lyophilisation with different cryoprotectant agents. Food Res Int 115:90–94. https://doi.org/10.1016/j.foodres.2018.07.044
Rebolledo C, Cuevas A, Zambrano T, Acuña JJ, Jorquera MA, Saavedra K, Martínez C, Lanas F, Serón P, Salazar LA (2017) Bacterial community profile of the gut microbiota differs between hypercholesterolemic subjects and controls. Biomed Res Int 2017:8127814–8127816. https://doi.org/10.1155/2017/8127814
Robinson JG, Wang S, Smith BJ, Jacobson TA (2009) Meta-analysis of the relationship between non–high-density lipoprotein cholesterol reduction and coronary heart disease risk. J Am Coll Cardiol 53(4):316–322
Ryan MP, Adley CC (2014) Ralstonia spp.: emerging global opportunistic pathogens. Eur J Clin Microbiol Infect Dis 33(3):291–304
Saffarian A, Touchon M, Mulet C, Tournebize R, Passet V, Brisse S, Rocha EP, Sansonetti PJ, Pédron T (2017) Comparative genomic analysis of Acinetobacter strains isolated from murine colonic crypts. BMC Genomics 18(1):525
Sanders ME, Morelli L, Tompkins TA (2003) Sporeformers as human probiotics: Bacillus, Sporolactobacillus, and Brevibacillus. Compr Rev Food Sci Food Saf 2(3):101–110
Schwartz RG, Barrett EJ, Francis CK, Jacob R, Zaret BL (1985) Regulation of myocardial amino acid balance in the conscious dog. J Clin Invest 75(4):1204–1211
Seyedan A, Alshawsh MA, Alshagga MA, Koosha S, Mohamed Z (2015) Medicinal plants and their inhibitory activities against pancreatic lipase: a review. J Evidence-Based Complementary Altern Med 2015:973143–973113. https://doi.org/10.1155/2015/973143
Sheng H, Rabinowitz JD (2018) An unexpected trigger for calorie burning in brown fat. Nature 560(7716):38-39
Shih K-C, Kwok C-F, Hwu C-M, Hsiao L-C, Li S-H, Liu Y-F, Ho L-T (1997) Acipimox attenuates hypertriglyceridemia in dyslipidemic noninsulin dependent diabetes mellitus patients without perturbation of insulin sensitivity and glycemic control. Diabetes Res Clin Pract 36(2):113–119
Shimizu M, Hashiguchi M, Shiga T, Tamura H-o, Mochizuki M (2015) Meta-analysis: effects of probiotic supplementation on lipid profiles in normal to mildly hypercholesterolemic individuals. PLoS One 10(10):e0139795
Taranto M, Fernandez Murga M, Lorca G, de Valdez GF (2003) Bile salts and cholesterol induce changes in the lipid cell membrane of Lactobacillus reuteri. J Appl Microbiol 95(1):86–91
Udayappan SD, Kovatcheva-Datchary P, Bakker GJ, Havik SR, Herrema H, Cani PD, Bouter KE, Belzer C, Witjes JJ, Vrieze A (2017) Intestinal Ralstonia pickettii augments glucose intolerance in obesity. PLoS One 12(11):e0181693
Velagapudi VR, Hezaveh R, Reigstad CS, Gopalacharyulu P, Yetukuri L, Islam S, Felin J, Perkins R, Borén J, Orešič M (2010) The gut microbiota modulates host energy and lipid metabolism in mice. J Lipid Res 51(5):1101–1112
Walzer G, Rosenberg E, Ron EZ (2006) The Acinetobacter outer membrane protein a (OmpA) is a secreted emulsifier. Environ Microbiol 8(6):1026–1032
Wang J, Tang H, Zhang C, Zhao Y, Derrien M, Rocher E, Vlieg JE-H, Strissel K, Zhao L, Obin M (2015) Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. ISME J 9(1):1–15
Wang M, Chen Y, Wang Y, Li Y, Zhang X, Zheng H, Ma F, Ma C, Lu B, Xie Z (2018) Beneficial changes of gut microbiota and metabolism in weaned rats with Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 supplementation. J Funct Foods 48:252–265
Wilson R, Willis J, Gearry R, Skidmore P, Fleming E, Frampton C, Carr A (2017) Inadequate vitamin C status in prediabetes and type 2 diabetes mellitus: associations with glycaemic control, obesity, and smoking. Nutrients 9(9):997
Wlodarska M, Luo C, Kolde R, D'Hennezel E, Annand JW, Heim CE, Krastel P, Schmitt EK, Omar AS, Creasey EA (2017) Indoleacrylic acid produced by commensal Peptostreptococcus species suppresses inflammation. Cell Host Microbe 22(1):25–37
Xie N, Cui Y, Yin YN, Zhao X, Yang JW, Wang ZG, Fu N, Tang Y, Wang XH, Liu XW (2011) Effects of two Lactobacillus strains on lipid metabolism and intestinal microflora in rats fed a high-cholesterol diet. BMC Complement Altern Med 11(1):53–53
Zhang C, Zhang M, Wang S, Han R, Cao Y, Hua W, Mao Y, Zhang X, Pang X, Wei C (2010) Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME J 4(2):232–241
Zhao L, Zhang Q, Ma W, Tian F, Shen H, Zhou M (2017) A combination of quercetin and resveratrol reduces obesity in high-fat diet-fed rats by modulation of gut microbiota. Food Funct 8:4644–4656
Zhong C-Y, Sun W-W, Ma Y, Zhu H, Yang P, Wei H, Zeng B-H, Zhang Q, Liu Y, Li W-X (2015) Microbiota prevents cholesterol loss from the body by regulating host gene expression in mice. Sci Rep 5:10512
Zhongyong G, Shouqun J, Chuntian Z, Zhimei T, Xiajing L (2015) Equol inhibits LPS-induced oxidative stress and enhances the immune response in chicken HD11 macrophages. Cell Physiol Biochem 36(2):611–621
Zouari R, Hamden K, El Feki A, Chaabouni K, Makni-Ayadi F, Kallel C, Sallemi F, Ellouze-Chaabouni S, Ghribi-Aydi D (2016) Protective and curative effects of Bacillus subtilis SPB1 biosurfactant on high-fat-high-fructose diet induced hyperlipidemia, hypertriglyceridemia and deterioration of liver function in rats. Biomed Pharmacother 84:323–329
Acknowledgments
The authors thank the Key Realm R&D Program of Guangdong Province and Guangdong Provincial Special Fund for Modern Agriculture Industry Technology Innovation Teams for financial support. We thank Novogene (Beijing, China) for the use of Illumina platform.
Funding
This work was supported by Key Realm R&D Program of Guangdong Province (grant number: 2018B020206001) and Guangdong Provincial Special Fund for Modern Agriculture Industry Technology Innovation Teams (grant number: 2019KJ125).
Author information
Authors and Affiliations
Contributions
Study concept and design: JH, NX, PL, and BD. Conducted the experiments: JH, NX, YS, SW, WT, and YL. Analysis and interpretation of data: JH, NX, YS, PL, and BD. Writing—original draft preparation: JH, NX, YS, and SW. Writing—review and editing: JH, NX, YS, SW, WT, YL, PL, and BD. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Ethics approval
All animal experiments were performed in compliance with the Chinese legislation on the use and care of laboratory animals and were carried out in Guangzhou Quality Supervision and Testing Institute (Approval No.: SYXK (Yue) 2014-0137). All animal experiments comply with the ARRIVE guidelines.
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(PDF 836 kb)
Rights and permissions
About this article
Cite this article
Huang, J., Xiao, N., Sun, Y. et al. Supplementation of Bacillus sp. DU-106 reduces hypercholesterolemia and ameliorates gut dysbiosis in high-fat diet rats. Appl Microbiol Biotechnol 105, 287–299 (2021). https://doi.org/10.1007/s00253-020-10977-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00253-020-10977-2